Reply to “A comment on ‘Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was’”
The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70149. There are no data used in this Reply to an earlier Comment to the journal. All data previously used in our publication that both the Comment and Reply refer to are in the publication or its supplement.
Authors
- Tewodros Eguale (ORCID: https://orcid.org/0000-0002-8268-0884)
- B Rittenhouse (ORCID: https://orcid.org/0000-0002-9928-2583)
- Alissa R. Segal
- Sultan Othman Alolayan
Institutions
- Brigham and Women's Hospital (US)
- Massachusetts College of Pharmacy and Health Sciences (US)
- Taibah University (SA)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1111/dom.70149
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00